Skip to main content
. 2020 May 18;5(Suppl 3):e000804. doi: 10.1136/esmoopen-2020-000804

Table 1.

Outpatients visit priorities for the management of pancreatic cancer

High priority Medium priority Low priority
Patients with newly diagnosed resectable cancer—convert as many visits as possible to telemedicine appointments and schedule a multidisciplinary assessment in order to plan surgery Established patients with new minor to moderate problems or symptoms—convert as many visits as possible to telemedicine appointments Postoperative patients with no complications
Potentially unstable patients (complications in the post-surgery recovery period: anastomotic leak, bleeding, acute pancreatitis, fistulae, pneumonitis; jaundice; acute abdominal pain consistent with upper or lower intestinal occlusion; symptomatic ascites) Follow-up visits considering patients at high risk of relapse Established patients with no new issues
Patients newly diagnosed with non-resectable (locally advanced) or metastatic cancer and symptoms such as jaundice, pain, weight loss Survival follow-up visits out of clinical trials